{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:04:49Z","timestamp":1794445489068,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\\u201303232"],"award-info":[{"award-number":["2018\\u201303232"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021\\u201302262"],"award-info":[{"award-number":["2021\\u201302262"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.atherosclerosis.2025.119227","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:01:11Z","timestamp":1746054071000},"page":"119227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Basal and exercise-induced expression of NLRP3 inflammasome-related components is increased in patients with chronic coronary syndrome"],"prefix":"10.1016","volume":"405","author":[{"given":"Zeid","family":"Mahmood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"B\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Leanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka","family":"Thune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Skoglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0586-6618","authenticated-orcid":false,"given":"Lena","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.119227_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119227_bib2","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and Anti-Interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119227_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.atherosclerosis.2025.119227_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2020.03.022","article-title":"The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease","volume":"301","author":"van 't Klooster","year":"2020","journal-title":"Atherosclerosis"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2025.119227_bib5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119227_bib6","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119227_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina","volume":"106","author":"Blankenberg","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.119227_bib8","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/ATVBAHA.109.202697","article-title":"Interleukin-18 as a predictor of future events in patients with acute coronary syndromes","volume":"30","author":"Hartford","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2025.119227_bib9","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1beta inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119227_bib10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/clc.23274","article-title":"Interleukin-18 in patients with acute coronary syndromes","volume":"42","author":"Akerblom","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119227_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijcard.2018.01.055","article-title":"Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease","volume":"257","author":"Schofer","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119227_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102985","article-title":"Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis","volume":"60","author":"Niyonzima","year":"2020","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.119227_bib13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2025.119227_bib14","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2025.119227_bib15","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119227_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/21623945.2015.1024394","article-title":"Is immunity a mechanism contributing to statin-induced diabetes?","volume":"4","author":"Henriksbo","year":"2015","journal-title":"Adipocyte"},{"key":"10.1016\/j.atherosclerosis.2025.119227_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biopha.2016.04.043","article-title":"Atorvastatin suppresses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-kappaB signaling in PMA-Stimulated THP-1 monocytes","volume":"82","author":"Kong","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2025.119227_bib18","first-page":"6","article-title":"The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review","volume":"15","author":"Ploeger","year":"2009","journal-title":"Exerc Immunol Rev"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.119227_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/07853890.2014.927713","article-title":"Exercise-induced changes in inflammatory processes: implications for thrombogenesis in cardiovascular disease","volume":"46","author":"Chen","year":"2014","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119227_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.amjcard.2007.11.006","article-title":"Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls","volume":"101","author":"Kop","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119227_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cyto.2018.02.006","article-title":"Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease","volume":"105","author":"Cwikiel","year":"2018","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119227_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78286-2","article-title":"The effect of acute exercise on interleukin-6 and hypothalamic-pituitary-adrenal axis responses in patients with coronary artery disease","volume":"10","author":"Mahmood","year":"2020","journal-title":"Sci Rep"},{"issue":"SUPPL 414","key":"10.1016\/j.atherosclerosis.2025.119227_bib23","first-page":"1","article-title":"Circulatory studies on healthy old men. With special reference to the limitation of the maximal physical working capacity","volume":"414","author":"Strandell","year":"1964","journal-title":"Acta Med Scand Suppl"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.119227_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1474515117743978","article-title":"Test\u2013retest reliability and responsiveness to change of clinical tests of physical fitness in patients with acute coronary syndrome included in the SWEDEHEART register","volume":"17","author":"Hellmark","year":"2018","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2025.119227_bib25","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119227_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1403494815602830","article-title":"Categorical answer modes provide superior validity to open answers when asking for level of physical activity: a cross-sectional study","volume":"44","author":"Olsson","year":"2016","journal-title":"Scand J Publ Health"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.119227_bib27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/(SICI)1096-9888(1998110)33:11<1134::AID-JMS730>3.0.CO;2-S","article-title":"Quantitative determination of ecteinascidin 743 in human plasma by miniaturized high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry","volume":"33","author":"Rosing","year":"1998","journal-title":"J Mass Spectrom"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119227_bib28","article-title":"NLRP3 inflammasome expression and activation in human atherosclerosis","volume":"5","author":"Paramel","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119227_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41398-020-01044-5","article-title":"Correction: whole-Blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study","volume":"10","author":"Cattaneo","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.119227_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2796.2007.01817.x","article-title":"Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity","volume":"262","author":"Nijm","year":"2007","journal-title":"J Intern Med"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.119227_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.119227_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/heart.88.5.467","article-title":"Increased plasma concentrations of interleukin-18 in acute coronary syndromes","volume":"88","author":"Mallat","year":"2002","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.119227_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.amjcard.2004.10.009","article-title":"Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease","volume":"95","author":"Nijm","year":"2005","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.119227_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.atherosclerosis.2005.11.013","article-title":"Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6","volume":"188","author":"Hulthe","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119227_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114385","article-title":"P2X7 receptor and the NLRP3 inflammasome: partners in crime","volume":"187","author":"Pelegrin","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119227_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-017-9593-0","article-title":"The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression","volume":"14","author":"Burnstock","year":"2018","journal-title":"Purinergic Signal"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502500125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191502500125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:51:56Z","timestamp":1777409516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191502500125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"alternative-id":["S002191502500125X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119227","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basal and exercise-induced expression of NLRP3 inflammasome-related components is increased in patients with chronic coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119227"}}